Condition: Paclitaxel-induced Peripheral Neuropathy · Sponsor: Department of Medical Services Ministry of Public Health of Thailand
The aim of this randomized controlled trial (RCT) is to compare the incidence of paclitaxel-induced grade 2 or higher sensory peripheral neuropathy, evaluated using the CTCAE version 5.0, between patients receiving surgical glove-compression therapy (SGCT) and those in the control group. The main question is whether SGCT is effective in preventing paclitaxel-induced sensory peripheral neuropathy. * Intervention group: receive SGCT. * Control group: receive non-compressive plastic gloves.
This description comes directly from the study's public registry record.
Saowani Thantaviraya, M.D. · +66805564241 · saowani.mook@gmail.com
Sunatee Sa-nguansai, M.D. · +66896949358 · sunatee@hotmail.com
Always discuss trial participation with your own doctor first.
| Rajavithi Hospital, Medical Oncology Unit | Bangkok, Bangkok, Thailand | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06763575